Alnylam Pharma (ALNY) Announces Management Appointments

Go back to Alnylam Pharma (ALNY) Announces Management Appointments

Alnylam Announces New Management Appointments

September 21, 2022 4:00 PM EDT

Piyush Sharma to Serve as Chief Ethics and Compliance Officer and Evan Lippman as Chief Corporate Development and Strategy Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the appointment of two new members to the management team... More